CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Apr. 30, 2013	Apr. 30, 2012
Current Assets
Cash and cash equivalents	$ 5,811	$ 6,188
Restricted cash	691	704
Receivables, less allowance: $194 (2013); $311 (2012)	25,884	22,469
Inventories	13,203	11,760
Deferred income taxes	654	713
Prepaid expenses and other current assets	987	989
Total Current Assets	47,230	42,823
Property, Plant and Equipment, Net	15,098	15,346
Other Assets
Deferred income taxes	2,241	1,656
Other	4,173	3,536
Total Other Assets	6,414	5,192
Total Assets	68,742	63,361
Current Liabilities
Short-term borrowings and interest rate swap	6,997	6,816
Current obligations under capital leases		36
Current portion of long-term debt	200	200
Accounts payable	10,406	8,848
Employee compensation and amounts withheld	2,076	1,304
Deferred revenue	488	587
Other accrued expenses	1,948	1,674
Total Current Liabilities	22,115	19,465
Long-term debt	3,267	3,467
Accrued pension and deferred compensation costs	9,667	8,771
Total Liabilities	35,049	31,703
Commitments and Contingencies (Note 7)
Stockholders' Equity
Common stock, $2.50 par value, Authorized - 5,000 shares; Issued - 2,620 shares; Outstanding - 2,592 shares (2013); 2,579 shares (2012)	6,550	6,550
Additional paid-in-capital	1,567	1,341
Retained earnings	31,191	29,218
Accumulated other comprehensive loss	(7,327)	(7,176)
Common stock in treasury, at cost: 27 shares (2013); 40 shares (2012)	(305)	(422)
Total Kewaunee Scientific Corporation Stockholders' Equity	31,676	29,511
Noncontrolling Interest	2,017	2,147
Total Equity	33,693	31,658
Total Liabilities and Stockholders' Equity	$ 68,742	$ 63,361